One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma☆ (original) (raw)
FLUTICASONE PROPIONATE/SALMETEROL VIA DISKUS IS SUPERIOR TO MONTELUKAST IN OVERALL ASTHMA CONTROL IN SUBJECTS WITH BOTH ASTHMA AND ALLERGIC RHINITIS
Giselle Mosnaim, John Oppenheimer
CHEST Journal, 2008
View PDFchevron_right
Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study
Andrzej Dymek
BMC Pulmonary Medicine, 2011
View PDFchevron_right
Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial
Stanley Szefler
Journal of Allergy and Clinical Immunology, 2011
View PDFchevron_right
Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/100??g vs Fluticasone Propionate 100??g in Adults and Adolescents with Asthma III: Results
Willem Pieters
PharmacoEconomics, 1999
View PDFchevron_right
Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy
May Hagiwara
Allergy and Asthma Proceedings, 2010
View PDFchevron_right
Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma
Sergio Iannazzo
Multidisciplinary Respiratory Medicine, 2016
View PDFchevron_right
Fluticasone versus placebo for chronic asthma in adults and children
Janine Bestall
Reviews, 1996
View PDFchevron_right
Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy
Emanuela Castelnuovo
Asthma Research and Practice, 2016
View PDFchevron_right
Recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma
Noel James Snell
International Journal of Pharmaceutical Medicine, 2002
View PDFchevron_right
EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma
Alexander Chuchalin
Respiratory Medicine, 2006
View PDFchevron_right
Effect of Combination Fluticasone Propionate and Salmeterol or Inhaled Corticosteroids on Asthma-Related Outcomes in a Medicare-Eligible Population
Melissa Roberts, Richard Stanford
The American Journal of Geriatric Pharmacotherapy, 2012
View PDFchevron_right
Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast
T. McLaughlin
Respiratory Medicine, 2001
View PDFchevron_right
Fifty μg b.i.d. of inhaled fluticasone propionate (FP) are effective in stable asthmatics previously treated with a higher dose of FP
Federico L. Dente
Respiratory Medicine, 2003
View PDFchevron_right
Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma
Kian Chung
Respiratory Medicine, 2004
View PDFchevron_right
Comparative Efficacy and Safety of Low-dose Fluticasone Propionate and Montelukast in Children with Persistent Asthma
Courtney Crim
The Journal of Pediatrics, 2005
View PDFchevron_right
Global Initiative for Asthma 2016–derived asthma control with fluticasone propionate and salmeterol
nadeem gul
Annals of Allergy, Asthma & Immunology, 2019
View PDFchevron_right
A Randomized Pragmatic Trial of Changing to and Stepping Down Fluticasone/Formoterol in Asthma
Andrew McLoughlin
The journal of allergy and clinical immunology. In practice, 2017
View PDFchevron_right
Efficacy and safety of fluticasone propionate 250 μg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids
Jorge Maspero
Annals of Allergy, Asthma & Immunology, 2002
View PDFchevron_right
Differences in recommendations between the Allergic Rhinitis and its Impact on Asthma Update 2010 and US Rhinitis Practice Parameters
Allan Luskin
Journal of Allergy and Clinical Immunology, 2011
View PDFchevron_right
Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
Richard Stanford
Journal of Asthma and Allergy, 2012
View PDFchevron_right
Economic Impact of Asthma Therapy With Fluticasone Propionate, Montelukast, or Zafirlukast In a Managed Care Population
Elizabeth Davis
Pharmacotherapy, 2002
View PDFchevron_right
Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class
Berrylin Ferguson, Michael Benninger
Annals of Allergy, Asthma & Immunology, 2010
View PDFchevron_right
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article
margitta worm
Journal of Allergy and Clinical Immunology, 2011
View PDFchevron_right
Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma I: Introduction and Overview
Willem Pieters
PharmacoEconomics, 1999
View PDFchevron_right
Comparison of the efficacy of inhaled fluticasone propionate, 880 μg/day, with flunisolide, 1500 μg/day, in moderate-to-severe persistent asthma
Shahid Iqbal sheikh
Annals of Allergy, Asthma & Immunology, 1999
View PDFchevron_right
Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma
Eric Bateman
CHEST Journal, 2013
View PDFchevron_right
Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations
Nemr Eid
Clinical Therapeutics, 2009
View PDFchevron_right
Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis
Nicola Martinelli
Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, 2004
View PDFchevron_right
Comparison of prevalence, cost, and outcomes of a combination of salmeterol and fluticasone therapy to common asthma treatments
Cary Sennett
The American journal of managed care, 2001
View PDFchevron_right
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone
Eric Bateman
Thorax, 2014
View PDFchevron_right
Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial
David Pearlman
The American Journal of Medicine, 2005
View PDFchevron_right
Symptom control in patients with asthma using inhaled corticosteroids/long-acting β2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study
Robson Lima
Journal of Asthma, 2021
View PDFchevron_right